Cargando…

Efficacy and safety of lenvatinib for preventing tumor recurrence after liver transplantation in hepatocellular carcinoma beyond the Milan criteria

BACKGROUND: Lenvatinib is one of the first-line treatments for unresectable hepatocellular carcinoma (HCC). However, data are lacking on lenvatinib in the postoperative setting. METHODS: This retrospective analysis enrolled 242 patients with HCC who underwent liver transplantation (LTx). Eligible pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, De-Zhen, Cheng, Jian-Wen, Yan, Jia-Yan, Huang, Ao, Wang, Yu-Peng, Zhang, Shi-Yu, Cao, Ya, Huang, Xiao-Wu, Fan, Jia, Zhou, Jian, Yang, Xin-Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9652551/ https://www.ncbi.nlm.nih.gov/pubmed/36388794 http://dx.doi.org/10.21037/atm-22-1353

Ejemplares similares

Liver transplantation for hepatocellular carcinoma beyond the Milan criteria
por: Xu, Xiao, et al.
Publicado: (2016)

Liver Transplantation Beyond Milan Criteria
por: Lingiah, Vivek A, et al.
Publicado: (2020)

Living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria: outcome of expanded criteria in tumor size
por: Liang, Hsin-Rou, et al.
Publicado: (2021)

Prognostic model for predicting outcome and guiding treatment decision for unresectable hepatocellular carcinoma treated with lenvatinib monotherapy or lenvatinib plus immunotherapy
por: Guo, De-Zhen, et al.
Publicado: (2023)

Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria: Multidisciplinary Approach to Improve Outcome
por: Kornberg, A.
Publicado: (2014)

Liver Transplantation in Patients with Hepatocellular Carcinoma beyond the Milan Criteria: A Comprehensive Review
por: Toniutto, Pierluigi, et al.
Publicado: (2021)

Circulating immune index predicting the prognosis of patients with hepatocellular carcinoma treated with lenvatinib and immunotherapy
por: Guo, De-Zhen, et al.
Publicado: (2023)

Sarcopenia as a predictor of post-transplant tumor recurrence after living donor liver transplantation for hepatocellular carcinoma beyond the Milan criteria
por: Kim, Young Ri, et al.
Publicado: (2018)

International study on the outcome of locoregional therapy for liver transplant in hepatocellular carcinoma beyond Milan criteria
por: Degroote, Helena, et al.
Publicado: (2021)

Comparison of the long‐term outcomes of patients with hepatocellular carcinoma within the Milan criteria treated by ablation, resection, or transplantation
por: Zhang, Ning‐Ning, et al.
Publicado: (2022)

Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma after Liver Resection: Retrospective Study of the Milan and Hangzhou Criteria
por: Hu, Zhenhua, et al.
Publicado: (2014)

Prediction of early recurrence of hepatocellular carcinoma within the Milan criteria after radical resection
por: Feng, Jiliang, et al.
Publicado: (2017)

Recurrence Beyond the Milan Criteria of HBV-Related Single Hepatocellular Carcinoma of 2–3 cm: Comparison of Resection and Ablation
por: Chen, Shuanggang, et al.
Publicado: (2021)

Living Donor Liver Transplantation: The Optimal Curative Treatment for Hepatocellular Carcinoma Even Beyond Milan Criteria
por: Alim, Altan, et al.
Publicado: (2021)

Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteria
por: Beumer, Berend R., et al.
Publicado: (2022)

Tenofovir vs. entecavir on recurrence of hepatitis B virus-related hepatocellular carcinoma beyond Milan criteria after hepatectomy
por: Shen, Junyi, et al.
Publicado: (2022)

Simple Risk Score for Prediction of Early Recurrence of Hepatocellular Carcinoma within the Milan Criteria after Orthotopic Liver Transplantation
por: Feng, Jiliang, et al.
Publicado: (2017)

Comparison of treatment outcome between living donor liver transplantation and sorafenib for patients with hepatocellular carcinoma beyond the Milan criteria
por: Cho, Yuri, et al.
Publicado: (2017)

Expansion of the hepatocellular carcinoma Milan criteria in liver transplantation: Future directions
por: Pavel, Mihai-Calin, et al.
Publicado: (2018)

Combined proteomic/transcriptomic signature of recurrence post-liver transplantation for hepatocellular carcinoma beyond Milan
por: Bhat, Mamatha, et al.
Publicado: (2021)

Expansion of the Milan criteria without any sacrifice: combination of the Hangzhou criteria with the pre-transplant platelet-to-lymphocyte ratio
por: Xia, Weiliang, et al.
Publicado: (2017)

Radiofrequency ablation following first-line transarterial chemoembolization for patients with unresectable hepatocellular carcinoma beyond the Milan criteria
por: Zhang, Lan, et al.
Publicado: (2014)

Sorafenib for hepatocellular carcinoma patients beyond Milan criteria after orthotopic liver transplantation: a case control study
por: Teng, Chieh-Lin, et al.
Publicado: (2012)

Patients Benefit from Liver Transplantation for Hepatocellular Carcinoma beyond Milan Criteria without Harming the Health Care System
por: Gundlach, Jan-Paul, et al.
Publicado: (2022)

Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation
por: Bang, Kyunghye, et al.
Publicado: (2022)

Is liver transplantation superior to liver resection for hepatocellular carcinoma within Milan criteria?
por: Feng, Qingbo, et al.
Publicado: (2022)

Surgical resection versus transarterial chemoembolization for patients with hepatocellular carcinoma beyond Milan criteria: prognostic role of tumor burden score
por: Ho, Shu-Yein, et al.
Publicado: (2023)

Transarterial chemoembolization with radiofrequency ablation versus hepatectomy in hepatocellular carcinoma beyond the Milan criteria: a retrospective study
por: Yuan, Hang, et al.
Publicado: (2018)

Retraction: Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma after Liver Resection: Retrospective Study of the Milan and Hangzhou Criteria
Publicado: (2019)

Long-Term Outcomes of Percutaneous Cryoablation for Patients with Hepatocellular Carcinoma within Milan Criteria
por: Rong, Guanghua, et al.
Publicado: (2015)

LIVER TRANSPLANTATION FOR CARCINOMA HEPATOCELLULAR IN SÃO PAULO: 414 CASES BY THE MILAN/BRAZIL CRITERIA
por: SÁ, Gustavo Pilotto D., et al.
Publicado: (2016)

Recurrence Outcome in Hepatocellular Carcinoma within Milan Criteria Undergoing Microwave Ablation with or without Transarterial Chemoembolization
por: Chen, Guobin, et al.
Publicado: (2022)

Predicting outcomes for recurrent hepatocellular carcinoma within Milan criteria after complete radiofrequency ablation
por: Chen, Hsin-Yeh, et al.
Publicado: (2020)

Second Hepatectomy Improves Survival in Patients With Microvascular Invasive Hepatocellular Carcinoma Meeting the Milan Criteria
por: Hou, Yi-Fu, et al.
Publicado: (2015)

Preoperative sintilimab plus transarterial chemoembolization for hepatocellular carcinoma exceeding the Milan criteria: A phase II trial
por: Guo, Chengxiang, et al.
Publicado: (2023)

Liver Transplantation for Hepatocellular Carcinoma: A Real-Life Comparison of Milan Criteria and AFP Model
por: Brusset, Bleuenn, et al.
Publicado: (2021)

Preoperative Albumin-Bilirubin Score for Postoperative Solitary Hepatocellular Carcinoma within the Milan Criteria and Child-Pugh A Cirrhosis
por: Dong, Zhao-Ru, et al.
Publicado: (2017)

MicroRNA Profile Predicts Recurrence after Resection in Patients with Hepatocellular Carcinoma within the Milan Criteria
por: Sato, Fumiaki, et al.
Publicado: (2011)

Liver transplantation versus surgical resection for HCC meeting the Milan criteria: A propensity score analysis
por: Shen, Jun-Yi, et al.
Publicado: (2016)

Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteria
por: Ochi, Hironori, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_r8m9ktnq734fi1dgvj4r795tq0